| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-11 | NCT07758595 A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT05371613 | A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase… | Mucopolysaccharidosis II | Recruiting |
| NCT06075537 | An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp… | Mucopolysaccharidosis II | Enrolling by Invitation |
| Phase 2 | |||
| NCT06602193 | Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated… | Parkinson Disease | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT04251026 | A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome | Mucopolysaccharidosis II | Active, Not Recruiting |
| NCT05262023 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… | Frontotemporal Dementia | Active, Not Recruiting |
| NCT06181136 | Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA… | Mucopolysaccharidosis Type IIIA | Active, Not Recruiting |
| Phase 1 | |||
| NCT07354724 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult… | Late-onset Pompe Disease | Recruiting |
| NCT07328451 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… | Alzheimer Disease, Early Onset | Recruiting |
| NCT07758595 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in… | Alzheimer's Disease | Not Yet Recruiting |